Skip to main content
. 2020 Mar;61(3):437–442. doi: 10.2967/jnumed.119.232603

FIGURE 4.

FIGURE 4.

(A) Ex vivo biodistribution (2 h after injection) with single 18F-CDKi injection or with preinjection of palbociclib (blocked). (B) Significance of tumor %ID/g between 18F-CDKi and blocked control group. (C) Tumor-to-nontarget (NT) ratio for blood, muscle, and bone (n = 4). Int = intestine.